Moneycontrol PRO

business

Exports to US will continue normally post audit: Dishman Pharma

Two minor observations pertaining to a 2014 audit were reported by the US FDA in its recent inspection, says JR Vyas, CMD of Dishman Pharma.

first published: Jul 11, 2016 11:53 am

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347